1. Home
  2. WKC vs STOK Comparison

WKC vs STOK Comparison

Compare WKC & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKC
  • STOK
  • Stock Information
  • Founded
  • WKC 1984
  • STOK 2014
  • Country
  • WKC United States
  • STOK United States
  • Employees
  • WKC N/A
  • STOK N/A
  • Industry
  • WKC Oil Refining/Marketing
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKC Energy
  • STOK Health Care
  • Exchange
  • WKC Nasdaq
  • STOK Nasdaq
  • Market Cap
  • WKC 1.4B
  • STOK 1.3B
  • IPO Year
  • WKC N/A
  • STOK 2019
  • Fundamental
  • Price
  • WKC $25.98
  • STOK $21.48
  • Analyst Decision
  • WKC Hold
  • STOK Strong Buy
  • Analyst Count
  • WKC 4
  • STOK 8
  • Target Price
  • WKC $28.75
  • STOK $30.00
  • AVG Volume (30 Days)
  • WKC 551.2K
  • STOK 1.5M
  • Earning Date
  • WKC 10-23-2025
  • STOK 11-04-2025
  • Dividend Yield
  • WKC 3.09%
  • STOK N/A
  • EPS Growth
  • WKC N/A
  • STOK N/A
  • EPS
  • WKC N/A
  • STOK 0.91
  • Revenue
  • WKC $37,648,100,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • WKC N/A
  • STOK $416.54
  • Revenue Next Year
  • WKC $2.16
  • STOK N/A
  • P/E Ratio
  • WKC N/A
  • STOK $27.93
  • Revenue Growth
  • WKC N/A
  • STOK 1218.82
  • 52 Week Low
  • WKC $22.71
  • STOK $5.35
  • 52 Week High
  • WKC $31.54
  • STOK $38.69
  • Technical
  • Relative Strength Index (RSI)
  • WKC 52.50
  • STOK 28.95
  • Support Level
  • WKC $25.55
  • STOK $24.50
  • Resistance Level
  • WKC $26.19
  • STOK $33.88
  • Average True Range (ATR)
  • WKC 0.56
  • STOK 2.14
  • MACD
  • WKC 0.06
  • STOK -1.57
  • Stochastic Oscillator
  • WKC 59.06
  • STOK 7.80

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: